The emerging role of non-coding RNAs in the pathogenesis of infantile hemangioma. [PDF]
Saki N +3 more
europepmc +1 more source
Crosstalk between acetylation modification and autophagy in cancer: roles, mechanisms, and therapeutic potential. [PDF]
Liu Y +5 more
europepmc +1 more source
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor. [PDF]
Delaidelli A +20 more
europepmc +1 more source
Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation. [PDF]
Muntiu A +12 more
europepmc +1 more source
A comprehensive review of tear fluid proteome alterations in dry eye disease: Insights into pathophysiology and biomarker potential. [PDF]
Ahmed S +5 more
europepmc +1 more source
Related searches:
MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells
Molecular Biotechnology, 2022Aberrant gene expression caused by miRNAs disorders plays a relevant role in multiple steps of tumorigenesis. In this attempt, we studied the functional role of miR-125b-5p and TPD52 in breast cancer. TPD52 mRNA and miR-125b-5p levels were assessed via qRT-PCR, and TPD52 protein level was analyzed via western blot.
Yuezhen Wang, Jun Fang, Feiying Gu
exaly +3 more sources
The tumor protein D52 (TPD52) is an oncogene overexpressed in prostate cancer (PC) due to gene amplification. Although the oncogenic effect of TPD52 is well recognized, how its expression is regulated is still not clear. This study tried to explore the regulative role of miR-218, a tumor suppressing miRNA on TPD52 expression and prostate cancer cell ...
Guangye Han
exaly +3 more sources
Acute myeloid leukaemia (AML) is a blood cancer where undifferentiated myeloid cells are increased in the bone marrow and peripheral blood. As AML is dangerous and shows poor prognosis, many researchers categorised the relevant cytogenetic factors ...
Ji Wan Kang +2 more
exaly +2 more sources
TPD52: A Novel Vaccine Target for Prostate Cancer
Abstract : As outlined in our approved statement of work, the goals of this Award are to test the efficacy of TPD52-based vaccines in the TRAMP murine model of prostate cancer, and to characterize vaccine induced mechanisms of tumor immunity. Specifically, we have begun to evaluate the ability of TPD52-DNA-based vaccines given intramuscularly to induce
Heather N. Schultz +2 more
openaire +2 more sources

